Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
4.29B | 2.71B | 3.34B | 2.91B | 2.79B | Gross Profit |
4.29B | 2.71B | 3.34B | 2.91B | 2.79B | EBIT |
1.01B | 1.05B | 1.34B | 1.45B | 672.00M | EBITDA |
1.01B | 1.03B | 1.26B | 1.43B | 758.00M | Net Income Common Stockholders |
784.00M | 680.00M | 907.00M | 1.13B | 539.00M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
9.13B | 2.25B | 13.91B | 34.93B | 17.35B | Total Assets |
88.78B | 87.20B | 89.55B | 93.20B | 81.48B | Total Debt |
4.78B | 2.07B | 7.75B | 1.01B | 1.34B | Net Debt |
4.78B | -137.00M | 5.75B | -9.87B | -281.00M | Total Liabilities |
82.65B | 81.51B | 84.65B | 1.01B | 1.34B | Stockholders Equity |
6.12B | 5.69B | 4.89B | 7.46B | 7.89B |
Cash Flow | Free Cash Flow | |||
1.47B | 772.00M | 1.28B | 423.00M | 548.00M | Operating Cash Flow |
1.47B | 885.00M | 1.47B | 629.00M | 719.00M | Investing Cash Flow |
1.41B | 2.37B | 1.41B | -11.58B | -12.20B | Financing Cash Flow |
-2.81B | -3.20B | -2.81B | 11.00B | 11.32B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
74 Outperform | $22.55B | 12.72 | 9.83% | 3.83% | 10.13% | -1.25% | |
72 Outperform | $28.93B | 13.86 | 11.78% | 3.34% | 11.21% | -2.26% | |
72 Outperform | $20.25B | 11.57 | 10.59% | 4.24% | 2.70% | -8.16% | |
71 Outperform | $71.41B | 13.13 | 10.82% | 3.35% | 7.24% | 7.51% | |
69 Neutral | $7.55B | 10.31 | 12.80% | 3.17% | 7.91% | 13.79% | |
64 Neutral | $14.34B | 10.61 | 9.28% | 4.07% | 18.04% | -9.54% | |
63 Neutral | $7.82B | 11.89 | 10.67% | 4.54% | -6.54% | -21.90% |